advisorsecurities master

GRMLGreenland Mines Ltd. Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key
16222
Ticker
GRML
Type
CSCommon Stock
Exchange
Nasdaq(XNAS)
Venue group
NASDAQ
Operating MIC
XNAS
Market
stocks
Locale
us
Currency
USD
Listed
2026-03-12
Round lot
100
Active
Yes
Last seen in a load
2026-08-14 20:49
Vendor updated
2026-08-13 06:09
Ticker root / suffix
GRML

Detail

Enriched 2026-08-14 20:47

Market cap
$30,753,127.82
Shares outstanding (class)
138,129,260
Shares outstanding (weighted)
150,529,260
SIC
2836 BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees
5
Location
OMAHA, NE
Description

Greenland Mines Ltd develops essential medicines for the treatment of chronic diseases - cancer, cardiovascular, and neurodegenerative disorders. The Company operates as a single reporting segment focused on developing essential medicines for these chronic diseases. The Company has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and proprietary patented technologies involving melanocortin receptor-binding molecules and a gene therapy platform that introduces a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases.

Market cap and share counts drift.

Funds holding this security

Identifiers

Classification

Fund data